OBJECTIVES: HIV-1 bound extracellularly to follicular dendritic cells (FDC) in germinal centers (GC) of lymphoid tissues (LT) represents the largest viral reservoir in HIV-infected individuals; however there is no direct evidence as to whether HIV trapped in human GC remains infectious. In the GC, complement receptors and Fc gamma receptors have been suggested to participate in trapping of HIV; therefore, the relative contribution of complement- and Fc gamma receptors in binding HIV on LT was investigated and the infectivity of this virus was tested. DESIGN: As it is difficult to isolate FDC without contaminations of productively infected cells, HIV was detached from LT of HIV positive individuals using antibodies blocking complement- and Fc gamma receptors. Isolated virus was tested in an infectivity assay. METHODS: HIV detached from LT was quantified by HIV p24 ELISA, PCR and in an in vitro infectivity assay. Presence and accessibility of viral envelope proteins, complement factors and immunoglobulins on the surface of detached viral particles were evaluated through viral capture by respective antibodies. RESULTS: Although both C3d-fragments and IgG molecules were identified on the surface of HIV detached from LT, trapping of HIV was mediated solely by CR2-C3d interactions, whereas contribution of Fc gamma receptors was not detectable. Infectivity assays with HIV stripped from LT of HIV positive individuals revealed that in four out of ten patients HIV particles were infectious. CONCLUSIONS: These findings indicate that in the GC infectious virus is trapped on CR2-expressing FDC (or B cells). Reduction of this pool of HIV could be a therapeutic goal.
OBJECTIVES:HIV-1 bound extracellularly to follicular dendritic cells (FDC) in germinal centers (GC) of lymphoid tissues (LT) represents the largest viral reservoir in HIV-infected individuals; however there is no direct evidence as to whether HIV trapped in human GC remains infectious. In the GC, complement receptors and Fc gamma receptors have been suggested to participate in trapping of HIV; therefore, the relative contribution of complement- and Fc gamma receptors in binding HIV on LT was investigated and the infectivity of this virus was tested. DESIGN: As it is difficult to isolate FDC without contaminations of productively infected cells, HIV was detached from LT of HIV positive individuals using antibodies blocking complement- and Fc gamma receptors. Isolated virus was tested in an infectivity assay. METHODS: HIV detached from LT was quantified by HIV p24 ELISA, PCR and in an in vitro infectivity assay. Presence and accessibility of viral envelope proteins, complement factors and immunoglobulins on the surface of detached viral particles were evaluated through viral capture by respective antibodies. RESULTS: Although both C3d-fragments and IgG molecules were identified on the surface of HIV detached from LT, trapping of HIV was mediated solely by CR2-C3d interactions, whereas contribution of Fc gamma receptors was not detectable. Infectivity assays with HIV stripped from LT of HIV positive individuals revealed that in four out of ten patients HIV particles were infectious. CONCLUSIONS: These findings indicate that in the GC infectious virus is trapped on CR2-expressing FDC (or B cells). Reduction of this pool of HIV could be a therapeutic goal.
Authors: Rajnish S Dave; Ravi K Sharma; Roshell R Muir; Elias Haddad; Sanjeev Gumber; Francois Villinger; Artinder P Nehra; Zafar K Khan; Brian Wigdahl; Aftab A Ansari; Siddappa N Byrareddy; Pooja Jain Journal: J Neuroimmune Pharmacol Date: 2017-12-29 Impact factor: 4.147
Authors: Niki M Moutsopoulos; Salvador Nares; Nikolaos Nikitakis; Zoila Rangel; Jie Wen; Peter Munson; John Sauk; Sharon M Wahl Journal: Am J Pathol Date: 2007-07-09 Impact factor: 4.307
Authors: Maria E Moreno-Fernandez; Julio Aliberti; Sander Groeneweg; Jörg Köhl; Claire A Chougnet Journal: AIDS Res Hum Retroviruses Date: 2015-12-15 Impact factor: 2.205
Authors: Claudia R Ruprecht; Anders Krarup; Lucy Reynell; Axel M Mann; Oliver F Brandenberg; Livia Berlinger; Irene A Abela; Roland R Regoes; Huldrych F Günthard; Peter Rusert; Alexandra Trkola Journal: J Exp Med Date: 2011-02-28 Impact factor: 14.307